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This review discusses research methodology in the relation between diet and disease. Medical research
can be divided into two types: complex research (the detailed study of disease mechanisms using such
methods as biochemistry and molecular genetics) and simple research (the investigation of the factors that
cause or prevent disease using methods such as epidemiology, intervention trials, and analagous studies
on animals). Although complex research has received the bulk of resources, the large majority of our
information of practical value has come from simple research. This general principle is illustrated in the
area of diet and disease by examples from various areas: selenium, carotenoids, and cancer; vitamin E,
-3 fatty acids, and coronary heart disease; dietary fat and obesity; dietary sodium and hypertension; and
alcohol and stroke. Discussion then turns to aspects of the design of cohort (prospective) studies. Because
of problems of sample size and relative lack of diversity, previous studies often failed to give clear-cut
results. Suggestions are made concerning the design of cohort studies, notably the use of much larger
numbers of subjects and with greater diversity in their diets. The problem of confounding also is
discussed. Lifestyle factors often cluster together but cohort studies may not have fully unraveled
this. Nutrition 2002;18:343–347. ©Elsevier Science Inc. 2002
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INTRODUCTION
Great progress has been made since the 1970s in elucidating the
relation between diet and disease. In this review the various
research strategies are discussed to draw conclusions as to the
types of research that have been most successful in advancing our
knowledge. I also discuss specific problems in the design of cohort
(prospective) studies. In addition, attention is turned to the prob-
lem of confounding.
SIMPLE AND COMPLEX RESEARCH
The human body may be likened to a black box of immense
complexity. Various factors enter the black box and the end result
is health or disease. Ideally, one may wish for a proper under-
standing of the inner working of the black box. In practice,
however, identifying the relation between incoming factors (diet,
lifestyle, and the environment) and resulting health and disease is
sufficient for an understanding of how to prevent disease. Based on
this analogy medical research has been divided into two types:
complex and simple.1–3
Complex Research
This type of research consists of studies of disease mechanisms.
The large majority of studies in such areas as biochemistry, phys-
iology, and molecular genetics are examples of complex research.
This type of research appeals to the human sense of curiosity.
However, disease mechanisms usually prove to be so complex that
we enter an almost never-ending quest for clear answers. This type
of research is also referred to as mechanistic or reductionist
research.
Simple Research
This type of research comprises those types of study where the
results directly indicate what factors cause or prevent disease. Of
course, the research itself may not be simple. The main forms of
simple research are epidemiologic studies (ecologic, case-control,
and cohort studies), intervention trials in humans, and analagous
studies on animals. Biochemical and physiological measurements
may be included with simple research if they are clear indicators of
disease risk. Examples of such parameters include blood levels of
cholesterol, glucose, and insulin.
The words complex and simple refer to the degree of complex-
ity in translating observations into practical knowledge that can be
applied to problems of human health.
In the area of diet and disease, as much as in any area of
medical research, an objective evaluation shows that simple re-
search has generated most of the important information of practical
value. The following examples illustrate the superior value of
simple research.
SELENIUM AND CANCER. There is considerable evidence
from population comparison data4 and animal studies5,6 that sele-
nium is anticarcinogenic. Findings from case-control and cohort
studies have also supported a role for selenium.4 An intervention
study showed a halving in cancer mortality in subjects given
selenium supplements.7 Thus, this evidence from simple research
has been of great value in identifying a means of preventing much
cancer cheaply and safely, namely by increasing the population
intake of this mineral by increasing dietary intake or using sup-
plementation. Studies of the biochemistry of selenium (complex
research) have found several possible mechanisms of action.4
However, the complexity involved is such that the findings are of
no apparent practical value.
CAROTENOIDS AND CANCER. In 1981 Peto et al.8 proposed
that -carotene prevents cancer. This inspired a large research
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effort to investigate the hypothesis.9 Possible mechanisms include
antioxidant activity, increased metabolic detoxification, and anti-
inflammatory action. At the same time many case-control and
cohort studies found a strong inverse relationship between intake
of -carotene and risk of cancer. Based on that finding, several
intervention trials were conducted. However, these generated no
evidence that supplements of -carotene prevent cancer. Attention
is now turning to other carotenoids, such as lutein and lycopene,
and to other components of fruit and vegetables.
Complex research (i.e., mechanistic studies) has made little
contribution to our understanding of the relation between carote-
noids and cancer. Indeed, such research may well have shone more
darkness than light on the subject because it created a false belief
that -carotene prevents cancer. On this occasion epidemiology
also produced false clues. In retrospect, there was a general failure
to appreciate that the protective association between -carotene
and cancer might easily be due to confounding by other compo-
nents in fruit and vegetables. This is certainly an area where
epidemiology shows its limitations. Perhaps the one piece of hard
information to emerge from those studies is that it is dietary
patterns, namely a relatively high intake of fruit and vegetables,
that provides the surest route to the prevention of cancer. The one
reliable way to make progress is by intervention trials.
VITAMIN E AND CORONARY HEART DISEASE. Another
important dietary antioxidant is vitamin E. It is effective in en-
hancing the resistance of low-density lipoprotein to oxidation.10
Based on that finding, it was believed that vitamin E supplements
would prevent coronary heart disease (CHD). Indeed, even though
the evidence lacks consistency, some epidemiologic studies have
suggested an inverse association between vitamin E intake, espe-
cially from supplements, and risk of CHD.10 As a result of those
findings, intervention trials were conducted. Subjects at high risk
of CHD were given vitamin E or placebo. Although there was
some evidence of a reduction in non-fatal CHD, vitamin E does not
appear to prevent CHD death.11–14 Perhaps of most significance,
the total mortality was actually increased slightly in groups given
supplemental vitamin E.14,15
Arguably, the clearest lesson that we learn from all this is that
biochemical studies, in this case the effect of vitamin E on low-
density lipoprotein oxidation, is an unreliable basis for predicting
whether a substance will prevent disease. The inconsistency of the
epidemiologic findings and the proneness of such data to generate
misleading associations because of the problem of confounding
should have made clinical investigators more cautious before
large-scale intervention trials were launched.
-3 FATTY ACIDS AND CHD. Evidence from several case-
control and cohort studies showed an inverse association between
fish consumption and risk of CHD.16 As a high content of long-
chain -3 fatty acids is the most pronounced nutritional difference
between fish and other foods, this was the obvious food component
responsible for the benefit. This provided a firm basis for inter-
vention trials using fatty fish or fish oil. These in turn have
provided solid evidence that long-chain -3 fatty acids are pro-
tective against CHD.11,17
It is noteworthy that there have been few biochemical studies
into how -3 fatty acids affect the cardiovascular disease process.
The absence of such studies has clearly in no way hindered
progress.
DIETARY FAT AND OBESITY. In 1998 there was a debate in
the pages of the American Journal of Clinical Nutrition concerning
the role of excess dietary fat in obesity.18,19 What is noteworthy
about this debate is that the only data referred to came from simple
research. The types of study mainly discussed were laboratory
studies and intervention trials that investigated the interrelation-
ships between dietary fat, energy intake, satiety, metabolic rate,
and weight change. Also discussed were epidemiologic studies and
animal studies (the effect of high-fat diets on weight gain in
animals). In contrast, no reference was made to complex research
such as the large literature on intermediary metabolism. Thus it
appears that the debaters found little of value in that area.
DIETARY SODIUM AND HYPERTENSION. Another debate
that took place in the American Journal of Clinical Nutrition
concerned the relative contribution of dietary sodium to hyperten-
sion and the effectiveness of sodium restriction as a therapy.20,21
The types of study discussed were from simple research, namely
population comparisons, intervention trials, and animal studies
(the effect of high-salt diets on blood pressure in animals). There
was a limited discussion of the findings from complex research
(i.e., the mechanisms by which excess sodium affects the blood
pressure), but there was little indication that these data were of
particular importance in resolving the question. Rather, it appears
that the mechanisms of action of salt on blood pressure were
discussed mainly to help explain the findings from simple research.
Indeed, it is common that, after a study based on simple research
has pointed to a relation between a dietary factor and a disease (or
a parameter closely associated with a disease), various mecha-
nisms are then discussed to explain the findings.
ALCOHOL AND STROKE. It is well established that excessive
alcohol intake tends to increase blood pressure. This fact strongly
suggests that alcohol should be positively associated with the risk
of stroke. This is indeed the case in heavy drinkers.22 However, in
recent years, case-control studies23 and one cohort study24 have
found that, as with CHD, light to moderate consumers of alcohol
actually have a reduced risk of stroke. This unexpected observation
stems entirely from simple research. The great many studies in
such areas as the action of alcohol in the body and the pathophys-
iology of blood vessels made no apparent contribution to this
serendipitous discovery.
LESSONS TO BE LEARNED
In the those examples we see a dearth of evidence that complex
research has been of significant practical value in improving our
understanding of the relation between diet and disease. Contrary
examples can, of course, be pointed to. A number of new drugs
may owe their origin to complex research. But, overall, an enor-
mous research effort into the etiology of disease has contributed
remarkably little to disease prevention. In contrast, although it is
difficult to be exact, simple research has received well under half
of the resources available for medical research but has generated
the large majority of information of practical value.
Perhaps the area where there has been the greatest misdirection
of resources is in cancer research. There has been an enormous
research effort into the study of such complex areas as the metab-
olism of carcinogens and oncogenetics. Nevertheless, the bulk of
our knowledge concerning how to prevent cancer comes from
simple studies into the relation between lifestyle and environmen-
tal factors (mainly diet and smoking) and the risk of cancer.25
There is no reason to believe that the lessons from the past
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several decades have been learned. Indeed, it is the seldom dis-
puted dogma that studies of disease mechanisms—reductionism—
is the basis for medical advance. The largest current focus of
medical research is into the human genome and how an under-
standing of it can be translated into new cures for disease. The
complexity of this challenge is so immense that one must be highly
pessimistic that any significant success will be achieved, certainly
not within the foreseeable future.
The research strategy that has proven most productive has been
a combination of epidemiologic studies followed by intervention
trials. Important findings have come from all forms of epidemio-
logic investigations, both population comparisons (ecologic stud-
ies) and studies within a population (case-control and cohort
studies). Often valuable results have also come from simple re-
search on animals, such as the study of the effect of dietary fat on
weight and of selenium on cancer incidence in animals exposed to
carcinogens.
Aside from intervention trials, which are still the undisputed
gold standard, of the different types of simple research, the one
that has proven of most value has been cohort studies. But there
have been several instances of misleading findings. Reference was
made to the case of -carotene and risk of cancer and to vitamin
E and risk of CHD. In the next section, I turn my attention to the
design of cohort studies.
COHORT STUDIES
The Nurses’ Health Study commenced in 1976 and is based on
detailed information collected from 121 700 American female
nurses. Similarly, the Health Professionals. Follow-up Study,
which started in 1986, is based on 51 500 American male health
professionals. These studies have generated large amounts of valu-
able information. Despite costs running into several millions of
dollars each year, few would disagree that they are excellent value
for the money.
Even with the seemingly enormous size of these studies, many
of the observations have not been statistically significant; this is
because the sample size still poses limitations. This is illustrated by
the following examples.
1. In the Health Professionals Follow-up Study, 812 new cases
of prostate cancer developed in the first 6 y. Lycopene, a
carotenoid found in tomatoes, showed a negative association
with this disease (relative risk [RR] 0.79), but the relation
was only marginally significant.25 Whereas tomatoes and
tomato sauce showed an inverse relationship, tomato juice
did not. These results may be of considerable importance for
the prevention of this fairly common cancer. Nevertheless,
despite an apparent 21% fall in risk, the results were not
clear-cut.
2. In a publication on the Nurses’ Health Study, findings were
presented based on 442 cases of colon cancer that developed
during 14 y.26 A high intake of multivitamins containing
folate was associated with a decreased risk. The RRs were
0.83 at years 5 to 9 and 0.80 at years 10 to 14; neither
association was significant. However, the association be-
came strong and significant after 15 y (RR  0.25). These
results produced uncertainty as to whether folate supple-
ments given for fewer than 10 y lead to an appreciable
reduction in the risk of colon cancer.
3. In another report from the Nurses’ Health Study, data were
given based on 2956 cases of breast cancer that developed
during 14 y.27 The surprising observation associated trans
fatty acids with an 8% decreased risk but -3 fatty acids
from fish with a 9% increased risk. Both associations were
marginally significant. Possibly these observations were due
to confounding or represented only random “noise.” Alter-
nately, they may be real; in that case they are potentially
important, for the control of this important cancer and our
understanding of the health and safety effects of various
types of fat.
To gain a clearer picture, it is necessary to expand the sample
sizes of the cited studies several-fold because to halve the confi-
dence intervals the population size must increase by a factor of
four. Studies with such sample sizes would help clarity the roles of
major factors in minor diseases and of minor factors in major
diseases. For example, we would better understand the role of diet
in gallstones, arthritis, osteoporosis, eye disease, stroke, various
less common cancers, Alzheimer’s disease, and the decline in
memory and lung function with aging.
Studies of this size would also help clarify the role of antioxi-
dants and phytochemicals in various diseases. The data would
indicate which protective substances have the strongest (inverse)
associations with disease. Moreover, the large sample size would
facilitate dealing with the problem of confounding (see THE PROB-
LEM OF CONFOUNDING).
Relative lack of diversity of diets has been a shortcoming of
previous studies. For instance, in the Nurses’ Health Study, the
mean fat intake in the lowest quintile was 32% of total energy,28
a level well above a low-fat diet. In the Health Professionals
Follow-up Study, the median intake of vitamin C in the lowest
quintile was 92 mg,29 which indicates that the entire sample had an
adequate intake. In that study, the median intake of dietary fiber in
the highest quintile was 28.9 g,30 a level still well short of a truly
high-fiber intake.
The effect of a lack of diversity is that the resulting RR moves
closer to unity.31 For example, if the RR of a high versus low
intake of vitamin X for risk of cancer is 0.6 in a population with
a wide range of intake, then the RR may be 0.8 where the range of
intake is less. As a result, more subjects are required to achieve the
same level of statistical significance. Thus, sample size and diver-
sity are closely related: as the degree of diversity increases, the
number of subjects required to detect a significant difference
decreases.
To enhance diversity, it would be valuable to throw the net
across much of Europe. Inclusion of economically poor countries
such as Cyprus, Albania, Ukraine, and Romania would magnify
contrasts in diet and lifestyle. Another advantage of recruiting
across Europe is to facilitate recruitment. Other possible regions
suitable for study are the Americas (North, South, and Caribbean)
and the countries of East and Southeast Asia.
The ideal population for such a study is one that could be
followed for at least 20 y, consists of reasonably responsible and
cooperative people aged 40 to 50 y, and have a high degree of
variability in diet and lifestyle. For instance, physicians may have
less value than other people because they generally have low rates
of smoking. Suitable groups might include teachers, civil servants,
police, and nurses.
Three large cohort studies have been launched in recent
years.32–34 In each case subjects were recruited from the general
population. One is being done as part of the Women’s Health
Initiative.32 It comprises 100 000 women aged 50 to 79 y who are
being followed for 9 y. The statistical power is therefore compa-
rable to the that of Nurses’ Health Study. The other two studies are
much larger. However, both have a focus on cancer and the design
suggests that minimal effort will be made toward collection of data
relevant to other diseases, especially non-fatal ones. The European
Prospective Investigation Into Cancer and Nutrition study involves
484 000 men and women from nine countries of the European
Union.33 The age range at baseline is 35 (women) or 40 (men) to
between 60 and 74 y. The Multiethnic Cohort Study is being
carried out on 215 250 men and women age 45 to 75 y at
baseline.34 The subjects are from the ethnically diverse populations
of Hawaii and Los Angeles. One limitation of this study is that
blood samples were not collected.
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THE PROBLEM OF CONFOUNDING
The problem of confounding is a ubiquitous problem in cohort
studies. Insufficient attention has been paid to the tendency for
various lifestyle factors to cluster together; examples follow.
1. In the Nurses’ Health Study, women in the lowest quintile
for folate intake had higher levels of smoking but lower
levels of regular exercise compared with women in the
middle quintile (36.9 versus 26.4% for smoking and 35.0
versus 47.1% for exercise, respectively).35
2. In the Health Professionals Follow-up Study, men in the
lowest quintile for intake of -carotene and vitamins C and
E took only half as much exercise but were 56% to 100%
more likely to smoke compared with those in the top
quintile.36
3. Consistent with the previous study, a survey of American
adults associated low intake of fruit and vegetables with
being sedentary, a heavy smoker, and a heavy drinker.37
4. A study in Wisconsin indicated that users of supplements
tended to be female, better educated, to have a relatively low
body mass index, to have never smoked, to be more likely
to exercise, and to consume a more nutrient-dense diet.38
These data point to clustering of lifestyle factors. A healthy
lifestyle cluster includes exercise, not smoking, and consuming a
relatively high intake of fruit, vegetables, and various nutrients, but
less animal fat. In theory, these factors should not present a
problem in cohort studies because they can be corrected for in
multivariate analysis. However, Marshall and Greenland39 drew
attention to the problem of how measurement errors of strong
confounders can lead to erroneous conclusions with regard to the
relation between a weak risk factor and outcome. An example of
this is the protective association between intake of -carotene and
cancer. It is possible that inaccurate estimations of smoking (a
strong confounder) may have exaggerated the strength of the
negative association between -carotene and cancer.
Other factors may be associated with a healthy lifestyle and
have generally been overlooked in previous studies. Such factors
include avoidance of passive smoking, early diagnosis of disease
combined with better treatment, and perhaps differences in psy-
chological functioning. Socioeconomic status also has strong as-
sociations with health.40–42 Socioeconomis status includes eco-
nomic status, job status, education, and area of residence.
However, it is doubtful whether previous cohort studies have fully
corrected for it. As a result of these various associations, cohort
studies often have unrecognized errors of confounding. Margetts43
recently discussed the question of confounding in cohort studies.
CONCLUSION
This review is not a blueprint for fruitful research but may be a
source of stimulating ideas that will lead to more insightful plan-
ning of research strategies. Most importantly, there should be a
paradigm change in our priorities for nutrition research and, more
generally, medical research. That means a reduced emphasis on
“glamor” areas, most notably genomic medicine. There should
instead be a higher priority toward such lines of research as how
dietary patterns affect disease risk, the role of particular dietary
components (such as phytochemicals), and the potential value of
dietary supplements.
Cohort studies have played a vital role in unraveling the asso-
ciations between diet and disease. However, in recent years there
has been a growing appreciation of the various sources of error
associated with this research tool. In particular, cohort studies need
to be carried out on a truly large scale (200 000 to 400 000
subjects) and with wide diversity of diet and lifestyle. At the same
time, we need a better understanding of how to minimize errors
caused by confounding. This will entail improved accuracy of how
various parameters are estimated and a better appreciation of the
factors that may lead to confounding.
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